论文部分内容阅读
《新英格兰医学杂志》(New England Journal of Medicine)在2012年5月24日发表了阿司匹林预防复发性静脉血栓栓塞[华法林和阿司匹林(warfasa)]研究的结果。该项研究表明当患者存在无诱因静脉血栓栓塞并已停止抗凝治疗,且严重出血的风险没有明显增加时,使用阿司匹林治疗可以降低复发静脉血栓栓塞的风险(N Engl J Med,2012,366:1959-1967)。无诱因静脉血栓栓塞患者,在口服抗凝药治疗结束后2年内,约有20%的患者会复发。
On May 24, 2012, the New England Journal of Medicine published the results of a study of aspirin in the prevention of recurrent venous thromboembolism (warfarin and warfasa). The study showed that aspirin treatment reduced the risk of recurrent venous thromboembolism when patients had antiviral venous thromboembolism and had stopped anticoagulant therapy without a significant increase in the risk of major bleeding (N Engl J Med, 2012, 366: 1959-1967). In patients with no evidence of venous thromboembolism, about 20% of patients relapse within 2 years of oral anticoagulation therapy.